WASHINGTON, May 13 – Sen. Bernie Sanders (I-VT), Ranking Member of the Senate Budget Committee, and Rep. Elijah Cummings (D-MD), the Chairman of the House Committee on Oversight and Reform, responded to revelations that generic drug companies reportedly engaged in an effort to obstruct a 2014 congressional investigation launched by the two lawmakers into the firms’ price-fixing practices:

“Executives at a dozen leading pharmaceutical companies reportedly were found to have engaged in an unprecedented cover-up. They deleted their text messages, coordinated their responses, and lied to our offices in order to conceal a massive conspiracy to fix prices for generic drugs, raising them by as much as 1,000 percent. Read More



Related news: Israeli Firm Tied to Tool That Uses WhatsApp Flaw to Spy on Activists

ok.os